Skip to main content Accessibility help
×
×
Home

Botulinum toxin for Frey's syndrome: a closer look at different treatment responses

  • A Steffen (a1), N Rotter (a2), I R König (a3) and B Wollenberg (a1)

Abstract

Objective:

Botulinum toxin is a widely accepted, effective treatment for Frey's syndrome. While some patients need only one injection, others require repeated treatments. We aimed to describe the clinical features of patients with a more challenging treatment course.

Design:

Literature review and retrospective analysis of eight consecutive patients treated at a university hospital.

Subjects:

These patients' treatment responses were categorised (using our own system) and compared with those of 25 published cases.

Results:

Combined analysis identified no significant correlation between treatment response and age, gender or the extent of primary salivary gland surgery. There was no significant correlation between botulinum toxin dosage and time between treatments.

Conclusion:

Frey's syndrome should be viewed as a dynamic process in which the stimulus for aberrant reinnervation of parasympathetic nerve fibres can be reduced, in some patients, with higher botulinum toxin dose injections to the treated areas. However, responses are unpredictable, and relapses may occur at different time points and in different areas.

Copyright

Corresponding author

Address for correspondence: Dr Armin Steffen, Klinik für HNO-Heilkunde, Ratzeburger Allee 160, 23538 Lübeck, Germany Fax: + 49 451 500 6065 E-mail: armin.steffen@uk-sh.de

References

Hide All
1Matthes, P, Kruegel, J, Karapantzou, C, Winterhoff, J, Laskawi, R. Use of botulinum toxin in ORL departments in Germany [in German]. HNO 2010;58:452–8
2Drobik, C, Laskawi, R. Frey's syndrome: treatment with botulinum toxin [in German]. HNO Aktuell 1994;2:142–4
3Drobik, C, Laskawi, R. Frey's syndrome: treatment with botulinum toxin. Acta Otolaryngol (Stockh) 1995;115:459–61
4Clayman, MA, Clayman, SM, Seagle, MB. Review of the surgical and medical treatment of Frey syndrome. Ann Plast Surg 2006;57:581–4
5Minor, V. A new method to the clinical examination of sweating [in German]. Dtsch Nervenheilk 1928;101:302–8
6Wang, CC, Wang, CP. Preliminary experience with botulinum toxin type A intracutaneous injection for Frey's syndrome. J Chin Med Assoc 2005;68:463–7
7Laccourreye, O, Akl, E, Gutierrez-Fonseca, R, Garcia, D, Brasnu, D, Bonan, B. Recurrent gustatory sweating (Frey syndrome) after intracutaneous injection of botulinum toxin type A: incidence, management, and outcome. Arch Otolaryngol Head Neck Surg 1999;125:283–6
8Bakke, M, Thorsen, NM, Bardow, A, Dalager, T, Thomsen, CE, Reguer, L. Treatment of gustatory sweating with low-dose botulinum toxin A. Acta Odontol Scand 2006;64:129–33
9Pornprasit, M, Chintrakarn, C. Treatment of Frey's syndrome with botulinum toxin. J Med Assoc Thai 2007;90:2397–402
10Capaccio, P, Torretta, S, Osio, M, Minorati, D, Ottaviani, F, Sambataro, G et al. Botulinum toxin therapy: a tempting tool in the management of salivary secretory disorders. Am J Otolaryngol 2008;29:333–8
11Laccourreye, O, Muscatelo, L, Naude, C, Bonan, B, Brasnu, D. Botulinum toxin type A for Frey's syndrome: a preliminary prospective study. Ann Otol Rhinol Laryngol 1998;107:52–5
12Blitzer, A, Sulica, L. Botulinum toxin: basic science and clinical uses in otolaryngology. Laryngoscope 2001;111:218–26
13Laskawi, R, Drobik, C, Schonebeck, C. Up-to-date report of botulinum type A treatment in patients with gustatory sweating (Frey's syndrome). Laryngoscope 1998;108:381–4
14Hartl, DM, Julieron, M, LeRidant, AM, Janot, F, Marandas, P, Travagli, JP. Botulinum toxin A for quality of life improvement in post-parotidectomy gustatory sweating (Frey's syndrome). J Laryngol Otol 2008;122:1100–4
15Laskawi, R, Ellies, M, Rödel, R, Schoenebeck, C. Gustatory sweating: clinical implications and etiologic aspects. J Oral Maxillofac Surg 1999;57:642–8
16Nolte, D, Gollmitzer, I, Loeffelbein, DJ, Hölzle, F, Wolff, KD. Botulinum toxin for treatment of gustatory sweating. A prospective randomized study. Mund Kiefer Gesichtschir 2004;8:369–75
17Guntinas-Lichius, O. Increased botulinum toxin type A dosage is more effective in patients with Frey's syndrome. Laryngoscope 2002;112:746–9
18Cantarella, G, Berlusconi, A, Mele, V, Cogiamanian, F, Barbieri, S. Treatment of Frey's syndrome with botulinum toxin type B. Otolaryngol Head Neck Surg 2010;143:214–18
19de Bree, R, Duyndam, JE, Kuik, DJ, Leemans, R. Repeated botulinum toxin type A injections to treat patients with Frey's syndrome. Arch Otolaryngol Head Neck Surg 2009;135:287–90
20Martos Díaz, P, Bances del Castillo, R, Mancha de la Plata, M, Naval Gías, L, Martínez Nieto, C, Lee, GY et al. Clinical results in the management of Frey's syndrome with injections of botulinum toxin. Med Oral Patol Oral Cir Bucal 2008;13:E248–52
21Luna Ortiz, K, Rascon Ortiz, M, Sanson Riofrio, JA, Villavicencio Valencia, V, Mosqueda Taylor, A. Control of Frey's syndrome in patients treated with botulinum toxin type A. Med Oral Patol Oral Cir Bucal 2007;12:E79–84
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed